Braeburn

Primary NAICS Code

325412

NAICS

325412

Headquarters

Plymouth Meeting, PA

UEI

MFMXM7RTXA54

CAGE

7N3H8

Legal name

BRAEBURN INC

PSC

6505

Braeburn is a pharmaceutical company dedicated to transforming the management of opioid use disorder through next-generation therapies. The company focuses on developing and delivering solutions for people living with the serious consequences of opioid addiction, with a mission to advance individualized dosing regimens and delivery options.

• PleoPharma, IncPleoPharma is a pharmaceutical company developing treatments for Cannabis Use Disorder (CUD) and Cannabis Withdrawal Syndrome (CWS). Their lead program, PP-01, is an oral prescription medication that has completed Phase 2 clinical trials.BOCA RATON, FL
• MAXONA Pharmaceuticals, IncMAXONA Pharmaceuticals is a clinical-stage pharmaceutical company leveraging innovation to develop the next generation of therapies to help patients maximize life. MAXONA's initial focus is on addressing the urgent need for new effective therapies that treat acute and chronic pain, without the side effects and addiction risks associated with NSAIDS and opioids. MAXONA's lead compound, MAX-001 is a non-opioid, non-NSAID oral therapy with a novel mechanism of action that is initially being developed in the U.S. to treat acute and chronic pain.MALVERN, PA
• Egalet CorporationEgalet Corporation is a fully integrated specialty pharmaceutical company focused on developing, manufacturing, and commercializing innovative treatments for pain. The company uses proprietary Guardian Technology to create abuse-deterrent oral products and markets approved products including OXAYDO™, SPRIX®, and ARYMO™ ER.WAYNE, PA
• Resilient LifescienceResilient Lifescience is a Pittsburgh-based startup developing a wearable medical device to automatically detect and reverse opioid overdose using naloxone. The company is committed to leveraging medical device technology to improve the lives of people living with opioid addiction.PITTSBURGH, PA